BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cresset Chemical Company Establishes New Versaphor Division to Provide High-quality Desktop Products


3/3/2010 1:15:40 PM

Welwyn Garden City - Cresset today announced that it has launched Versaphor, a new desktop applications division aimed at supplying high quality tools based on its molecular Fields technology to a range of markets, including: medicinal chemists, patent teams (internal and external counsel), pre-clinical safety teams and in-licensing teams.

Versaphor’s Field-based tools enable companies to find smarter answers to their chemistry questions and make quicker, better-informed decisions about which molecules deserve investment of time, effort and capital. Versaphor’s first products are medicinal chemistry and patent specific versions of the FieldStere bioisostere generator. The Medicinal Chemistry application allows medicinal chemists to generate highly innovative ideas for drug-like lead molecules in new areas of chemical space. The Patent application enables patent attorneys to identify and more accurately evaluate the ‘obviousness’ of new chemical filings and to develop stronger patent filings covering a wider range of structural diversity. Cresset’s Field-based tools have successfully been used by Computational Chemists for over 8 years to predict and compare the activity and properties of their lead compounds. Instead of relying on 2D structure, Cresset uses the Fields around molecules to assess their likely biological activity and properties, regardless of structural similarity. Cresset’s Fields provide an accurate, highly-condensed representation of the nature, size and location of the critical properties required for binding and instigating a specific therapeutic effect.

“The Versaphor division will develop Cresset’s core technology into market-specific applications, enabling diverse groups in pharmaceutical and biotech companies to realise the full benefits of Field based chemistry” said Bea Leigh, Chief Executive Officer, Cresset. “We will deliver tailored desktop applications through Versaphor, whilst continuing to focus on the developing needs of the computational chemistry market through Cresset.”

For further information, please visit www.versaphor.com

About Cresset Group Ltd

Cresset develops software for calculating and comparing the molecular Field characteristics of chemical compounds. Field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. Cresset’s Fields provide a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s Computational Chemistry products have integrated support for distributing computing, workflow implementations and flexible licensing. Cresset’s Field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 80 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->